Page last updated: 2024-09-05

tolvaptan and Death, Sudden, Cardiac

tolvaptan has been researched along with Death, Sudden, Cardiac in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambrosy, AP; Butler, J; Chatterjee, NA; Gheorghiade, M; Greene, SJ; Konstam, MA; Maggioni, AP; Mentz, RJ; O'Connor, CM; Patel, RB; Subacius, H; Swedberg, K; Udelson, JE; Vaduganathan, M; Zannad, F	1

Trials

1 trial(s) available for tolvaptan and Death, Sudden, Cardiac

Article	Year
Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial). The American journal of cardiology, 2018, 07-15, Volume: 122, Issue:2 Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Hospitalization; Humans; Incidence; Male; Risk Factors; Stroke Volume; Survival Rate; Tolvaptan; United States	2018

Article

Year

Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial).

The American journal of cardiology, 2018, 07-15, Volume: 122, Issue:2

Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Hospitalization; Humans; Incidence; Male; Risk Factors; Stroke Volume; Survival Rate; Tolvaptan; United States

2018